Literature DB >> 14968803

Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Final rule.

.   

Abstract

The Food and Drug Administration (FDA, we, our) is issuing a final regulation declaring dietary supplements containing ephedrine alkaloids adulterated under the Federal Food, Drug, and Cosmetic Act (the act) because they present an unreasonable risk of illness or injury under the conditions of use recommended or suggested in labeling, or if no conditions of use are suggested or recommended in labeling, under ordinary conditions of use. We are taking this action based upon the well-known pharmacology of ephedrine alkaloids, the peer-reviewed scientific literature on the effects of ephedrine alkaloids, and the adverse events reported to have occurred in individuals following consumption of dietary supplements containing ephedrine alkaloids.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14968803

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  27 in total

1.  Banned, but Not Forgotten: A Case of Ephedrine-Induced Psychosis.

Authors:  Thomas J. Kim; H W LeBourgeois
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

2.  Cardiotoxicity of Ma Huang/caffeine or ephedrine/caffeine in a rodent model system.

Authors:  J K Dunnick; G Kissling; D K Gerken; M A Vallant; A Nyska
Journal:  Toxicol Pathol       Date:  2007-08       Impact factor: 1.902

Review 3.  Potential Influence of Centrally Acting Herbal Drugs on Transporters at the Blood-Cerebrospinal Fluid Barrier and Blood-Brain Barrier.

Authors:  Lilian W Kibathi; SoHyun Bae; Scott R Penzak; Parag Kumar
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-12       Impact factor: 2.441

Review 4.  Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center.

Authors:  Stephen Bent
Journal:  J Gen Intern Med       Date:  2008-04-16       Impact factor: 5.128

5.  Combined Effects of Ephedrine-Containing Dietary Supplements, Caffeine, and Nicotine on Morphology and Ultrastructure of Rat Hearts.

Authors:  Christopher E Brown; Stanley E Trauth; Richard S Grippo; Bill J Gurley; Anne A Grippo
Journal:  J Caffeine Res       Date:  2012-09

Review 6.  Weighing the Evidence of Common Beliefs in Obesity Research.

Authors:  Krista Casazza; Andrew Brown; Arne Astrup; Fredrik Bertz; Charles Baum; Michelle Bohan Brown; John Dawson; Nefertiti Durant; Gareth Dutton; David A Fields; Kevin R Fontaine; Steven Heymsfield; David Levitsky; Tapan Mehta; Nir Menachemi; P K Newby; Russell Pate; Hollie Raynor; Barbara J Rolls; Bisakha Sen; Daniel L Smith; Diana Thomas; Brian Wansink; David B Allison
Journal:  Crit Rev Food Sci Nutr       Date:  2015       Impact factor: 11.176

7.  Mechanistic pharmacokinetic modelling of ephedrine, norephedrine and caffeine in healthy subjects.

Authors:  C Csajka; C A Haller; N L Benowitz; D Verotta
Journal:  Br J Clin Pharmacol       Date:  2005-03       Impact factor: 4.335

Review 8.  Herbs and alternative therapies: relevance to hypertension and cardiovascular diseases.

Authors:  Chaula K Vora; George A Mansoor
Journal:  Curr Hypertens Rep       Date:  2005-08       Impact factor: 5.369

9.  Impact of obesity on the toxicity of a multi-ingredient dietary supplement, OxyELITE Pro™ (New Formula), using the novel NZO/HILtJ obese mouse model: Physiological and mechanistic assessments.

Authors:  Charles M Skinner; Isabelle R Miousse; Laura E Ewing; Vijayalakshmi Sridharan; Maohua Cao; Haixia Lin; D Keith Williams; Bharathi Avula; Saqlain Haider; Amar G Chittiboyina; Ikhlas A Khan; Mahmoud A ElSohly; Marjan Boerma; Bill J Gurley; Igor Koturbash
Journal:  Food Chem Toxicol       Date:  2018-09-30       Impact factor: 6.023

10.  Gene expression profiling in male B6C3F1 mouse livers exposed to kava identifies--changes in drug metabolizing genes and potential mechanisms linked to kava toxicity.

Authors:  Lei Guo; Qiang Shi; Stacey Dial; Qingsu Xia; Nan Mei; Quan-zhen Li; Po-Chuen Chan; Peter Fu
Journal:  Food Chem Toxicol       Date:  2009-12-03       Impact factor: 6.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.